Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 887 | 869 | 730 | 5,489 | 5,181 |
| Cost of Goods | 117 | 132 | 124 | 1,750 | 1,880 |
| Gross Profit | 770 | 737 | 606 | 4,140 | 3,290 |
| Operating Expenses | 1,779 | 1,883 | 1,446 | 3,680 | 3,450 |
| Operating Income | -892 | -1,014 | -716 | 809 | 731 |
| Interest Expense | 66 | 110 | 118 | 130 | 150 |
| Other Income | 300 | 58 | 67 | 491 | 29 |
| Pre-tax Income | -658 | -1,066 | -767 | 1,170 | 610 |
| Income Tax | N/A | -40 | 40 | 60 | 0 |
| Net Income Continuous | -658 | -1,026 | -806 | 720 | 610 |
| Net Income Discontinuous | 11,216 | 392 | 1,027 | N/A | 0 |
| Net Income | $10,558 | $-634 | $220 | $720 | $610 |
| EPS Basic Total Ops | 41.60 | -2.40 | 0.80 | 3.20 | 2.40 |
| EPS Basic Continuous Ops | -2.40 | -4.00 | -3.20 | 3.20 | 2.43 |
| EPS Basic Discontinuous Ops | 44.44 | 1.55 | 4.08 | 13.67 | N/A |
| EPS Diluted Total Ops | 41.60 | -2.40 | 0.80 | 3.20 | 2.40 |
| EPS Diluted Continuous Ops | -2.40 | -4.00 | -3.20 | 3.20 | 2.40 |
| EPS Diluted Discontinuous Ops | 44.43 | 1.55 | 4.08 | 13.78 | N/A |
| EBITDA(a) | $-892 | $-1,014 | $-716 | $1,089 | $1,001 |